A phase I/IIa trial of ATX MS 1467 in patients with secondary progressive multiple sclerosis.

Trial Profile

A phase I/IIa trial of ATX MS 1467 in patients with secondary progressive multiple sclerosis.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 10 Mar 2008

At a glance

  • Drugs ATX MS 1467 (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Sponsors Apitope Technology
  • Most Recent Events

    • 10 Mar 2008 New trial record.
    • 05 Nov 2007 Initial results reported by Apitope Technology; full results expected Q1 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top